JNJ

173.56

+1.32%↑

ABBV

198.07

-0.35%↓

NVS

116.79

+0.8%↑

ABT

134.42

+1.78%↑

UNH

250.68

+2.57%↑

JNJ

173.56

+1.32%↑

ABBV

198.07

-0.35%↓

NVS

116.79

+0.8%↑

ABT

134.42

+1.78%↑

UNH

250.68

+2.57%↑

JNJ

173.56

+1.32%↑

ABBV

198.07

-0.35%↓

NVS

116.79

+0.8%↑

ABT

134.42

+1.78%↑

UNH

250.68

+2.57%↑

JNJ

173.56

+1.32%↑

ABBV

198.07

-0.35%↓

NVS

116.79

+0.8%↑

ABT

134.42

+1.78%↑

UNH

250.68

+2.57%↑

JNJ

173.56

+1.32%↑

ABBV

198.07

-0.35%↓

NVS

116.79

+0.8%↑

ABT

134.42

+1.78%↑

UNH

250.68

+2.57%↑

Search

AstraZeneca PLC ADR

Closed

73.59 -1.31

Overview

Share price change

24h

Current

Min

73.52

Max

73.74

Key metrics

By Trading Economics

Income

-923M

2.5B

Sales

1B

15B

P/E

Sector Avg

27.832

34.393

Dividend yield

2.12

Profit margin

16.947

Employees

94,300

EBITDA

-18M

5B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+24.72% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.12%

2.54%

Market Stats

By TradingEconomics

Market Cap

5.1B

231B

Previous open

74.9

Previous close

73.59

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

AstraZeneca PLC ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 lip 2025, 08:08 UTC

Earnings

AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth -- Update

29 lip 2025, 06:46 UTC

Earnings

AstraZeneca Books Record Quarterly Revenue as Oncology Boosts Growth

8 sie 2025, 10:51 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

1 sie 2025, 11:10 UTC

Hot Stocks

Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck -- WSJ

29 lip 2025, 11:02 UTC

Earnings

AstraZeneca 2Q Adj EPS $2.17 >AZN.LN

29 lip 2025, 11:02 UTC

Earnings

AstraZeneca 2Q EPS $1.58 >AZN.LN

29 lip 2025, 11:01 UTC

Earnings

AstraZeneca 2Q Rev $14.5B >AZN.LN

29 lip 2025, 11:00 UTC

Earnings

AstraZeneca Results: H1 and Q2 2025

29 lip 2025, 08:00 UTC

Market Talk
Earnings

AstraZeneca Holding Back on a Guidance Upgrade Disappoints -- Market Talk

29 lip 2025, 07:53 UTC

Market Talk
Earnings

AstraZeneca Continues to Deliver Under U.S. Tariff Threat -- Market Talk

29 lip 2025, 07:26 UTC

Market Talk
Earnings

AstraZeneca Shares Look Undervalued -- Market Talk

29 lip 2025, 06:03 UTC

Earnings

Analysts Saw AstraZeneca 2Q Total Revenue at $14.15B

29 lip 2025, 06:03 UTC

Earnings

AstraZeneca 2Q Total Revenue $14.46B

29 lip 2025, 06:03 UTC

Earnings

Analysts Saw AstraZeneca 2Q Core EPS at $2.16

29 lip 2025, 06:03 UTC

Earnings

AstraZeneca 2Q Core EPS $2.17

29 lip 2025, 06:02 UTC

Earnings

AstraZeneca Sees Core EPS Increasing by a Low Double-Digit Percentage

29 lip 2025, 06:02 UTC

Earnings

AstraZeneca Sees Total Revenue Increasing by a High Single-Digit Percentage

29 lip 2025, 06:02 UTC

Earnings

AstraZeneca Backs 2025 View

29 lip 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Rev $14.46B

29 lip 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Adj EPS $2.17

29 lip 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Pretax Pft $3.13B

29 lip 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Net Pft $2.45B

29 lip 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Oper Pft $3.51B

29 lip 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q EPS $1.57

28 lip 2025, 10:51 UTC

Market Talk

U.S.-EU Tariff Deal, Earnings Could Keep Pharma Rally Going -- Market Talk

22 lip 2025, 10:19 UTC

Market Talk

AstraZeneca's Big U.S. Spending Plans Could Put NY Listing on the Table -- Market Talk

22 lip 2025, 09:34 UTC

Hot Stocks

Stocks to Watch Tuesday: Coca-Cola, GM, AstraZeneca, NXP -- WSJ

9 lip 2025, 10:59 UTC

Market Talk

Pharma Companies Would Be Severely Hurt by 200% Tariff -- Market Talk

9 lip 2025, 09:17 UTC

Hot Stocks

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

28 maj 2025, 18:09 UTC

Earnings

Heart Disease Could Be a Goner When These New -2-

Peer Comparison

Price change

AstraZeneca PLC ADR Forecast

Price Target

By TipRanks

24.72% upside

12 Months Forecast

Average 93 USD  24.72%

High 97 USD

Low 85 USD

Based on 4 Wall Street analysts offering 12 month price targets forAstraZeneca PLC ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

4

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

N/A / 69.55Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AstraZeneca PLC ADR

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.